Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,518 public trials 2,834 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma

NCT01053949

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHRU-Hôpital Sud, avenue Laennec, Amiens, France
  • Hématologie, Hôpital Avicenne Bobigny, France
  • Hématologie, CHU, avenue G.Clemenceau Caen, France
  • Hématologie Clinique, CHU, Hôpital d'Enfants Dijon, France
View all 19 locations
View Trial Details
Completed

Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old

NCT04687761

Conditions
Age More 60yr, De Novo, Hematologic Diseases, +6 more
Locations
  • Hospital Universitario Príncipe de Asturias Alcalá de Henares, Spain
  • Hospital Clínic Barcelona, Spain
  • Hospital San Pedro de Alcántara Cáceres, Spain
  • Hospital Universitario de Jerez de La Frontera Jerez de la Frontera, Spain
View all 15 locations
View Trial Details
Completed

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

NCT02362035

Conditions
Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)

NCT06649006

Conditions
B-precursor Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Akita University Hospital Akita, Japan
  • Kyushu University Hospital Fukuoka, Japan
  • Kurume University Hospital Kurume-shi, Fukuoka, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
View Trial Details
Completed

Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)

NCT04093596

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Sarah Cannon/Colorado Blood Cancer Institute Denver, Colorado, United States
View Trial Details
Completed

IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients

NCT01009840

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
View all 13 locations
View Trial Details

Related conditions